在三阴性乳腺癌中准癌症干细胞可塑性
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Chinese and Western Medicine, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Exploration of targeted anti-tumor therapy
|January 12, 2024
概括
三重阴性乳腺癌 (TNBC) 是具有侵略性的,癌症干细胞 (CSC) 驱动进展. 准CSC可塑性为TNBC治疗提供了一个有前途的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 干细胞研究 干细胞研究
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择的侵袭性亚型.
- 癌症干细胞 (CSC) 涉及到TNBC的进展,转移和治疗耐药性.
- CSCs具有自我更新和分化能力,有助于瘤的启动和维护.
研究的目的:
- 审查了解TNBC癌症干细胞可塑性的最新进展.
- 探索驱动CSC可塑性的分子机制在这种攻击性癌症中.
- 讨论针对TNBC治疗中CSC可塑性的新型治疗策略.
主要方法:
- 关于TNBC和CSC的最新研究的文献综述.
- 对CSC可塑性背后的分子机制的分析.
- 综合现有和新兴的治疗方法.
主要成果:
- CSC 具有显著的可塑性,使其能够适应微环境变化.
- 这种可塑性是TNBC的攻击性和治疗耐药性的关键因素.
- 了解这些机制对于开发有效治疗方法至关重要.
结论:
- 准CSC可塑性为新型TNBC疗法提供了一个有希望的途径.
- 对CSC可塑性机制的进一步研究可能会释放新的治疗策略.
- 这种方法有可能改善TNBC患者的治疗结果.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


